Your browser doesn't support javascript.
loading
Neuroimaging biomarkers in Huntington's disease: Preparing for a new era of therapeutic development.
van Eimeren, Thilo; Giehl, Kathrin; Reetz, Kathrin; Sampaio, Cristina; Mestre, Tiago A.
Affiliation
  • van Eimeren T; University of Cologne, Faculty of Medicine, Department of Nuclear Medicine, Cologne, Germany; University of Cologne, Faculty of Medicine, Department of Neurology, Cologne, Germany. Electronic address: thilo.van-eimeren@uk-koeln.de.
  • Giehl K; University of Cologne, Faculty of Medicine, Department of Nuclear Medicine, Cologne, Germany; Research Center Jülich, Institute for Neuroscience and Medicine (INM-2), Jülich, Germany.
  • Reetz K; University of Aachen, Department of Neurology, Aachen, Germany.
  • Sampaio C; CHDI Management/CHDI Foundation, Princeton, NJ, USA.
  • Mestre TA; University of Ottawa, Department of Medicine, Division of Neurology, The Ottawa Hospital Research Institute, Parkinson's Disease and Movement Disorders Center, Canada.
Parkinsonism Relat Disord ; 114: 105488, 2023 09.
Article in En | MEDLINE | ID: mdl-37407343
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Huntington Disease Type of study: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Parkinsonism Relat Disord Journal subject: NEUROLOGIA Year: 2023 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Huntington Disease Type of study: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Parkinsonism Relat Disord Journal subject: NEUROLOGIA Year: 2023 Document type: Article Country of publication: United kingdom